Vaccinia virus entry, exit, and interaction with differentiated human airway epithelia

Journal of Virology

Volumn 81, Issue 18, 2007, Pages 9891-9899

  Vermeer, Paola D ^a   McHugh, Julia ^a   Rokhlina, Tatiana ^a   Vermeer, Daniel W ^a   Zabner, Joseph ^a   Welsh, Michael J ^a  

^a UNIVERSITY OF IOWA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR 1; GROWTH FACTOR RECEPTOR; UNCLASSIFIED DRUG; VACCINIA VIRUS GROWTH FACTOR; VIRUS PROTEIN; EPIDERMAL GROWTH FACTOR RECEPTOR; PEPTIDE; VACCINIA GROWTH FACTOR;

APICAL MEMBRANE; ARTICLE; BASOLATERAL MEMBRANE; CELL COUNT; CELL CULTURE; CELL PROLIFERATION; CONTROLLED STUDY; ELECTRIC CONDUCTIVITY; HUMAN; HUMAN CELL; NONHUMAN; PRIORITY JOURNAL; PROGENY; RESPIRATORY EPITHELIUM; TIGHT JUNCTION; VACCINIA VIRUS; VIRUS INFECTION; VIRUS REPLICATION; CELL DIFFERENTIATION; GROWTH, DEVELOPMENT AND AGING; METABOLISM; PATHOLOGY; PHYSIOLOGY; RESPIRATORY TRACT MUCOSA; SMALLPOX; SMALLPOX VIRUS; TIME; TISSUE CULTURE TECHNIQUE; VACCINIA; VIROLOGY; VIRUS INTERNALIZATION; VIRUS SHEDDING;

POXVIRIDAE; VACCINIA VIRUS; VARIOLA VIRUS;

CELL DIFFERENTIATION; ELECTRIC CONDUCTIVITY; HUMANS; PEPTIDES; RECEPTOR, EPIDERMAL GROWTH FACTOR; RESPIRATORY MUCOSA; SMALLPOX; TIGHT JUNCTIONS; TIME FACTORS; TISSUE CULTURE TECHNIQUES; VACCINIA; VACCINIA VIRUS; VARIOLA VIRUS; VIRUS INTERNALIZATION; VIRUS SHEDDING;

EID: 35348892064     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.00601-07     Document Type: Article

References (58)

1. Baron, S. 2003. Smallpox: the main site of transmission is the oropharynx. J. Dent. Res. 82:252.
2. Blasco, R., N. B. Cole, and B. Moss. 1991. Sequence analysis, expression, and deletion of a vaccinia virus gene encoding a homolog of profilin, a eukaryotic actin-binding protein. J. Virol. 65:4598-4608.
3. Blasco, R., and B. Moss. 1991. Extracellular vaccinia virus formation and cell-to-cell virus transmission are prevented by deletion of the gene encoding the 37,000-Dalton outer envelope protein. J. Virol. 65:5910-5920.
4. Blasco, R., and B. Moss. 1995. Selection of recombinant vaccinia viruses on the basis of plaque formation. Gene 158:157-162.
5. Buller, R. M., S. Chakrabarti, J. A. Cooper, D. R. Twardzik, and B. Moss. 1988. Deletion of the vaccinia virus growth factor gene reduces virus virulence. J. Virol. 62:866-874.
6. Buller, R. M., S. Chakrabarti, B. Moss, and T. Frederickson. 1988. Cell proliferative response to vaccinia virus is mediated by VGF. Virology 164:182-192.
7. Buller, R. M., and G. J. Palumbo. 1991. Poxvirus pathogenesis. Microbiol. Rev. 55:80-122.
8. Carter, G. C., M. Law, M. Hollinshead, and G. L. Smith. 2005. Entry of the vaccinia virus intracellular mature virion and its interactions with glycosaminoglycans. J. Gen. Virol. 86:1279-1290.
9. Chahroudi, A., R. Chavan, N. Kozyr, E. K. Waller, G. Silvestri, and M. B. Feinberg. 2005. Vaccinia virus tropism for primary hematolymphoid cells is determined by restricted expression of a unique virus receptor. J. Virol. 79:10397-10407.
10. Cohen, J. 2001. Bioterrorism. Blocking smallpox: a second defense. Science 294:500.
11. Cudmore, S., P. Cossart, G. Griffiths, and M. Way. 1995. Actin-based motility of vaccinia virus. Nature 378:636-638.
12. Dixon, C. W. 1962. Smallpox. J. & A. Churchill, Ltd., London, England.
13. Fath, K. R., S. N. Mamajiwalla, and D. R. Burgess. 1993. The cytoskeleton in development of epithelial cell polarity. J. Cell Sci. Suppl. 17:65-73.
14. Fenner, F., D. A. Henderson, I. Arita, Z. Jezek, and I. D. Ladnyi. 1988. Smallpox and its eradication, p. 10-14. World Health Organization, Geneva, Switzerland.
15. Guharoy, R., R. Panzik, J. A. Noviasky, E. P. Krenzelok, and D. C. Blair. 2004. Smallpox: clinical features, prevention, and management. Ann. Pharmacother. 38:440-447.
16. Hagen, S. J., and J. S. Trier. 1988. Immunocytochemical localization of actin in epithelial cells of rat small intestine by light and electron microscopy. J. Histochem. Cytochem. 36:717-727.
17. Hahon, N. 1961. Smallpox and relate poxvirus infections in the simian host. Bacteriol. Rev. 25:459-476.
18. Hahon, N., and B. J. Wilson. 1960. Pathogenesis of variola in Macaca irus monkeys. Am. J. Hyg. 71:69-80.
19. Hruby, D. E. 1990. Vaccinia virus vectors: new strategies for producing recombinant vaccines. Clin. Microbiol. Rev. 3:153-170.
20. Hsiao, J. C., C. S. Chung, and W. Chang. 1998. Cell surface proteoglycans are necessary for A27L protein-mediated cell fusion: identification of the N-terminal region of A27L protein as the glycosaminoglycan-binding domain. J. Virol. 72:8374-8379.
21. Isaacs, S. N. 2004. Working safely with vaccinia virus: laboratory technique and the role of vaccinia vaccination. Methods Mol. Biol. 269:1-14.
22. Jahrling, P. B., E. A. Fritz, and L. E. Hensley. 2005. Countermeasures to the bioterrorist threat of smallpox. Curr. Mol. Med. 5:817-826.
23. Karp, P. H., T. Moninger, S. P. Weber, T. S. Nesselhauf, J. Launspach, J. Zabner, and M. J. Welsh. 2002. An in vitro model of differentiated human airway epithelia: methods and evaluation of primary cultures. Epithelial Cell Culture Prot. 188:115-137.
24. Kates, J., and J. Beeson. 1970. Ribonucleic acid synthesis in vaccinia virus. I. The mechanism of synthesis and release of RNA in vaccinia cores. J. Mol. Biol. 50:1-18.
25. Kim, M., H. Yang, S. K. Kim, P. A. Reche, R. S. Tirabassi, R. E. Hussey, Y. Chishti, J. G. Rheinwald, T. J. Morehead, T. Zech, I. K. Damon, R. M. Welsh, and E. L. Reinherz. 2004. Biochemical and functional analysis of smallpox growth factor (SPGF) and anti-SPGF monoclonal antibodies. J. Biol. Chem. 279:25838-25848.
26. King, C. S., J. A. Cooper, B. Moss, and D. R. Twardzik. 1986. Vaccinia virus growth factor stimulates tyrosine protein kinase activity of A431 cell epidermal growth factor receptors. Mol. Cell. Biol. 6:332-336.
27. Lai, A. C., and B. G. Pogo. 1989. Attenuated deletion mutants of vaccinia virus lacking the vaccinia growth factor are defective in replication in vivo. Microb. Pathog. 6:219-226.
28. Lofquist, J. M., N. A. Weimert, and M. S. Hayney. 2003. Smallpox: a review of clinical disease and vaccination. Am. J. Health Syst. Pharm. 60:749-756, 757-758.
29. Luker, K. E., M. Hutchens, T. Schultz, A. Pekosz, and G. D. Luker. 2005. Bioluminescence imaging of vaccinia virus: effects of interferon on viral replication and spread. Virology 341:284-300.
30. McFadden, G. 2005. Poxvirus tropism. Nat. Rev. Microbiol. 3:201-213.
31. Moll, M., H. D. Klenk, G. Herrler, and A. Maisner. 2001. A single amino acid change in the cytoplasmic domains of measles virus glycoproteins H and F alters targeting, endocytosis, and cell fusion in polarized Madin-Darby canine kidney cells. J. Biol. Chem. 276:17887-17894.
32. Moss, B. 2006. Poxvirus entry and membrane fusion. Virology 344:48-54.
33. Nayak, D. P., E. K Hui, and S. Barman. 2004. Assembly and budding of influenza virus. Virus Res. 106:147-165.
34. Paschen. 1932. Pock diseases. Br. Med. J. 2:957-959.
35. Pennington, H. 2003. Smallpox and bioterrorism. Bull. W. H. O. 81:762-767.
36. Rodriguez, D., J. R. Rodriguez, G. K. Ojakian, and M. Esteban. 1991. Vaccinia virus preferentially enters polarized epithelial cells through the basolateral surface. J. Virol. 65:494-498.
37. Rossen, J. W. A., C. P. Bekker, W. F. Voorhout, G. J. Strous, A. van der Ende, and P. J. M. Rottier. 1994. Entry and release of transmissible gastroenteritis coronavirus are restricted to apical surfaces of polarized epithelial cells. J. Virol. 68:7966-7973.
38. Rusnak, D. W., K. Affleck, S. G. Cockerill, C. Stubberfield, R. Harris, M. Page, K. J. Smith, S. B. Guntrip, M. C. Carter, R. J. Shaw, A. Jowett, J. Stables, P. Topley, E. R. Wood, P. S. Brignola, S. H. Kadwell, B. R. Reep, R. J. Mullin, K. J. Alligood, B. R. Keith, R. M. Crosby, D. M. Murray, W. B. Knight, T. M. Gilmer, and K. Lackey. 2001. The characterization of novel, dual ErbB-2/EGFR, tyrosine kinase inhibitors: potential therapy for cancer. Cancer Res. 61:7196-7203.
39. Sakaguchi, M., Y. Yoshikawa, K. Yamanouchi, T. Sata, K. Nagashima, and K. Takeda. 1986. Growth of measles virus in epithelial and lymphoid tissues of cynomolgus monkeys. Microbiol. Immunol. 30:1067-1073.
40. Shelly, M., Y. Mosesson, A. Citri, S. Lavi, Y. Zwang, N. Melamed-Book, B. Aroeti, and Y. Yarden. 2003. Polar expression of ErbB-2/HER2 in epithelia. Bimodal regulation by Lin-7. Dev. Cell 5:475-486.
41. Sinn, P. L., G. Williams, S. Vongpunsawad, R. Cattaneo, and P. B. McCray, Jr. 2002. Measles virus preferentially transduces the basolateral surface of well-differentiated human airway epithelia. J. Virol. 76:2403-2409.
42. Smee, D. F., K. W. Bailey, M. H. Wong, and R. W. Sidwell. 2001. Effects of cidofovir on the pathogenesis of a lethal vaccinia virus respiratory infection in mice. Antivir. Res. 52:55-62.
43. Smith, G. L., and M. Law. 2004. The exit of vaccinia virus from infected cells. Virus Res. 106:189-197.
44. Smith, G. L., B. J. Murphy, and M. Law. 2003. Vaccinia virus motility. Annu. Rev. Microbiol. 57:323-342.
45. Smith, G. L., A. Vanderplasschen, and M. Law. 2002. The formation and function of extracellular enveloped vaccinia virus. J. Gen. Virol. 83:2915-2931.
46. Smith, S. A., and G. J. Kotwal. 2002. Immune response to poxvirus infections in various animals. Crit. Rev. Microbiol. 28:149-185.
47. Tegnell, A., B. Wahren, and F. Elgh. 2002. Smallpox - eradicated, but a growing terror threat. Clin. Microbiol. Infect. 8:504-509.
48. Turner, G. S. 1967. Respiratory infection of mice with vaccinia virus. J. Gen. Virol. 1:399-402.
49. Tzahar, E., J. D. Moyer, H. Waterman, E. G. Barbacci, J. Bao, G. Levkowitz, M. Shelly, S. Strano, R. Pinkas-Kramarski, J. H. Pierce, G. C. Andrews, and Y. Yarden. 1998. Pathogenic poxviruses reveal viral strategies to exploit the ErbB signaling network. EMBO J. 17:5948-5963.
50. Vermeer, P. D., L. A. Einwalter, T. O. Moninger, T. Rokhlina, J. A. Kern, J. Zabner, and M. J. Welsh. 2003. Segregation of receptor and ligand regulates activation of epithelial growth factor receptor. Nature 422:322-326.
51. Walters, R. W., T. Grunst, J. M. Bergelson, R. W. Finberg, M. J. Welsh, and J. Zabner. 1999. Basolateral localization of fiber receptors limits adenovirus infection from the apical surface of airway epithelia. J. Biol. Chem. 274:10219-10226.
52. Ward, B. M., and B. Moss. 2001. Visualization of intracellular movement of vaccinia virus virions containing a green fluorescent protein-B5R membrane protein chimera. J. Virol. 75:4802-4813.
53. Wehrle, P. F., J. Posch, K. H. Richter, and D. A. Henderson. 1970. An airborne outbreak of smallpox in a German hospital and its significance with respect to other recent outbreaks in Europe. Bull. W. H. O. 43:669-679.
54. Whitby, M., A. C. Street, T. A. Ruff, and F. Fenner. 2002. Biological agents as weapons 1: smallpox and botulism. Med. J. Aust. 176:431-433.
55. Widdicombe, J. H. 2002. Regulation of the depth and composition of airway surface liquid. J. Anat. 201:313-318.
56. Yang, H., S. K. Kim, M. Kim, P. A. Reche, T. J. Morehead, I. K. Damon, R. M. Welsh, and E. L. Reinherz. 2005. Antiviral chemotherapy facilitates control of poxvirus infections through inhibition of cellular signal transduc-tion. J. Clin. Investig. 115:379-387.
57. Zabner, J., P. Freimuth, A. Puga, A. Fabrega, and M. J. Welsh. 1997. Lack of high affinity fiber receptor activity explains the resistance of ciliated airway epithelia to adenovirus infection. J. Clin. Investig. 100:1144-1149.
58. Zaucha, G. M., P. B. Jahrling, T. W. Geisbert, J. R. Swearengen, and L. Hensley. 2001. The pathology of experimental aerosolized monkeypox virus infection in cynomolgus monkeys (Macaca fascicularis). Lab. Investig. 81:1581-1600.